Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Inflamm Bowel Dis. 2016 Aug;22(8):1923–1928. doi: 10.1097/MIB.0000000000000817

Table 2.

Corticosteroid Use and Escalation Rates to Corticosteroid-Sparing Mediations by Age

No
Corticosteroid
Use (NS)
Corticosteroid
use for IBD
(CS,IS,AS)
All
Corticosteroid
Users
(CS,IS,AS,OS)
Escalated
(Among
Corticosteroid
Users for IBD)
N % N % N % N % N %
Total Patients 30,456 100 20,575 100 6,054 100 9,881 100 2528 41.8
Age <25 707 2.3 323 45.7 341 48.2 384 54.3 212 62.2
Age 25–30 1009 3.3 483 47.9 450 44.6 526 52.1 261 58.0
Age 30–35 867 2.9 470 54.2 323 37.3 397 45.8 168 52.0
Age 35–40 1002 3.3 560 55.9 320 31.9 442 44.1 169 52.8
Age 40–45 1360 4.5 796 58.5 404 29.7 564 41.5 175 43.3
Age 45–50 1734 5.7 986 56.9 468 27.0 748 43.1 216 46.2
Age 50–55 2591 8.5 1626 62.8 597 23.0 965 37.2 238 39.9
Age 55–60 4498 14.8 2925 65.0 932 20.7 1573 35.0 401 43.0
Age 60–65 4412 14.5 3055 69.2 775 17.6 1357 30.8 320 41.3
Age 65–70 3266 10.7 2412 73.9 450 13.8 854 26.1 147 32.7
Age 70–75 3408 11.2 2605 76.4 398 6.6 803 23.6 114 28.6
Age 75–80 3174 10.4 2455 77.3 360 11.3 719 22.7 80 22.2
Age 80+ 2428 8.0 1879 77.4 236 3.9 549 5.6 27 11.4